Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants

被引：0
|
作者：
Rajeev Dhere
Vistasp Sethna
Hitesh Malviya
Rajeshwari Adhiseshan
机构：
[1] Serum Institute of India Private Limited,
来源：
Infectious Diseases and Therapy | 2022年 / 11卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1297 / 1299
页数：2
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN FILIPINO ADULTS AGED $50 YEARS
    Santiaguel, J.
    Nua, W.
    Atwood, M.
    Huang, L.
    Hariharan, D.
    Guerrero, J.
    Zotomayor, R. C.
    Averin, A.
    VALUE IN HEALTH, 2023, 26 (12) : S167 - S167
  • [22] COST-EFFECTIVENESS ANALYSIS OF JOINT VACCINATION WITH 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) AND INFLUENZA VACCINE IN TAIWAN DURING SEASONAL INFLUENZA
    Wu, D. B. C.
    Chong, H. Y.
    Lee, K. K. C.
    VALUE IN HEALTH, 2014, 17 (03) : A273 - A273
  • [23] Response to article by Johnna Perdrizet et al.,"Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants"
    Gomez, Jorge A.
    Pinto, Thatiana de Jesus Pereira
    Guevara, Javier Nieto
    Noronha, Tatiana Guimaraes de
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)
  • [24] THE COST-EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN CHINESE CITIES
    Furnback, W.
    Wang, B. C. M.
    Zhu, S.
    Dong, P.
    VALUE IN HEALTH, 2020, 23 : S170 - S170
  • [25] Cost-effectiveness of the 13-valent Pneumococcal Conjugate Vaccine in Children in Portugal
    Gouveia, Miguel
    Fiorentino, Francesca
    Jesus, Goncalo
    Costa, Joao
    Borges, Margarida
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (08) : 782 - 787
  • [26] COST-EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN ADULTS IN PORTUGAL
    Alarcao, J.
    Fiorentino, F.
    Gouveia, M.
    Jesus, G.
    Costa, J.
    Borges, M.
    VALUE IN HEALTH, 2016, 19 (07) : A414 - A414
  • [27] The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in England
    van Hoek, Albert Jan
    Choi, Yoon Hong
    Trotter, Caroline
    Miller, Elizabeth
    Jit, Mark
    VACCINE, 2012, 30 (50) : 7205 - 7213
  • [28] Impact of the 13-valent pneumococcal conjugate vaccine (pcv13) on invasive pneumococcal disease and carriage in Alaska
    Bruce, Michael G.
    Singleton, Rosalyn
    Bulkow, Lisa
    Rudolph, Karen
    Zulz, Tammy
    Gounder, Prabhu
    Hurlburt, Debby
    Bruden, Dana
    Hennessy, Thomas
    VACCINE, 2015, 33 (38) : 4813 - 4819
  • [29] A review of economic evaluations of 13-valent pneumococcal conjugate vaccine (PCV13) in adults and the elderly
    Dirmesropian, S.
    Wood, J. G.
    MacIntyre, C. R.
    Newall, A. T.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (04) : 818 - 825
  • [30] A COST-EFFECTIVENESS ANALYSIS OF VACCINATING THE ELDERLY WITH THE 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPV23) COMPARED TO NO VACCINATION, THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13), OR PCV13 FOLLOWED BY PPV23 IN BRAZIL
    Jiang, Y.
    Yang, X.
    Petigara, T.
    Chabrol Haas, L.
    Graham, J.
    VALUE IN HEALTH, 2017, 20 (09) : A930 - A930
12345